The Searle Company Limited (SEARL): Result Review – By Taurus Research
Oct 23 2025
Taurus Securities
- 1QFY26: – EPS: PKR 0.58, PAT: PKR 298Mn, down 30%YoY over the SPLY.
- In 1QFY26, top-line is expected to arrive at PKR 7.2Bn as compared to PKR 7.6Bn, down 5%YoY. Whereas, expected to increase 9%QoQ mainly due to the seasonal shift, favorable sales mix and deregulation of non-essential drugs. Gross margins are expected to increase 3pptsYoY driven by higher prices of medicines following deregulation. However, administrative expenses are likely to surge on the back of higher costs amid plans for launch of new products.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low
